Palantir Stock: Navigating Defense Contracts, Mining Deals, and Valuation Concerns

Palantir posts strong Q4 2025 results and wins key defense contracts, but its high P/E ratio and insider share sales create investor uncertainty.

While Palantir Technologies continues to secure high-profile contracts in defense and commercial sectors, its share price faces persistent headwinds. The core investment narrative revolves around the disconnect between the company's explosive growth and its premium valuation, a tension that currently overshadows its operational successes.

Financial Performance and Lofty Valuation

The company's fourth-quarter 2025 results demonstrated significant momentum. Revenue reached $1.41 billion, marking a 70% year-over-year increase. Its U.S. commercial business was a particular standout, soaring 137% to $507 million. Earnings per share came in at $0.25, exceeding analyst forecasts.

However, the market's reception is tempered by valuation metrics. The stock trades at a price-to-earnings ratio of approximately 239, a level that leaves little room for operational missteps or growth deceleration. This concern is compounded by notable insider selling activity. Over the past 90 days, company insiders disposed of roughly 1.045 million shares, valued at $140.5 million. Co-founder Peter Thiel further reduced his position by selling two million shares in March 2026.

Strategic Positioning in Defense and Intelligence

Palantir is deepening its integration within U.S. national security infrastructure. The company was recently designated as the core software developer for the U.S. "Golden Dome" missile defense initiative. In a parallel development, the Pentagon elevated the Maven Smart System to a "Program of Record" status. This formal classification guarantees long-term funding and ensures the system's integration across Department of Defense operations, solidifying Palantir's role in the military's artificial intelligence ecosystem.

Commercial Expansion Beyond Government

On the commercial front, Palantir has added mining equipment giant Metso as a client. Metso, which operates in more than 50 countries, will implement Palantir's AIP platform for predictive maintenance. This application is critical in an industry where unexpected machinery failures can result in losses exceeding several million dollars per hour.

Despite these gains, the company experienced a minor setback in its healthcare vertical. The New York City municipal hospital system has decided not to renew its contract with Palantir, set to expire in October 2026. The agreement, in place since 2023 for patient data management and worth about $4 million, represents a non-material financial loss. Nevertheless, it highlights ongoing scrutiny in the sector, where Palantir's substantial £330 million contract with Britain's National Health Service (NHS) remains under regulatory observation.

Outlook and Market Performance

For the full 2026 fiscal year, Palantir has provided guidance forecasting U.S. commercial revenue to surpass $3.14 billion. The pivotal question for investors is whether the current share price already fully reflects this anticipated growth. The equity is trading approximately 12% below its 200-day moving average and has declined nearly 14% since the start of the calendar year, suggesting market skepticism persists. The interplay between execution on its large contracts and its rich valuation will likely determine its trajectory in the coming quarters.